[1］ 陈子江. 雌激素在妇科内分泌疾病中的应用［M］. 北京：清华同方光盘电子出版社， 2012：1-6.

[2］ 田秦杰. 非口服雌孕激素的药物剂型及临床应用特点［J］. 实用妇产科杂志,2011,27(1):8-10.

[3］ Kuhl H， limacteric. Pharmacology of estrogens and progestogens: influence of different routes of administration［J］.Int Menopause Soc， 2005 ，8 （Suppl 1）:3-6.

[4］ Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study［J］. Circulation, 2007, 115(7): 840-845．

[5］ Laliberte F, Dea K, Duh MS, et al. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy［J］. Menopause,2009,18(10): 1052-1059.

[6］ Straczek C, Oger E, Marianne B，et al. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration［J］. Circulation, 2005,112:3495-3500.

[7］ Canonico M，Plu-Bureau G，Gordon DO,et al. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis［J］. BMJ, 2008,336(7655):1227-1231.

[8］ de Villiers TJ, Pines A,Panay N, et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health［J］. Climacteric,2013,16:316-337.

[9］ De Villiers TJ, Gass ML, Haines CJ, et al. Global consensus statement on menopausal hormone therapy［J］.Climacteric,2013;16(2):203-204.

[10］ 中华医学会妇产科学分会绝经学组. 绝经过渡期和绝经后期激素补充治疗临床应用指南（2012 版）［J］. 中华妇产科杂志,2013:48(10):795-799.

[11］ 中华医学会妇产科学分会绝经学组. 绝经相关激素补充治疗的规范诊疗流程［J］.中华妇产科杂志,2013,48(2):155-158.

[12］ Liu B, Beral V. Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study［J］. BMJ, 2008,10:337.

[13］ Modena MG, Sismondi P. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits［J］. Maturitas, 2005,52(1):1-10.

[14］ The American College of Obstetricians and Gynecologists.Management of menopausal symptoms［J］.Obstet Gynecol,2014, 123(1):202-216.